Dr. Robert E. Weiss is the Harris L. Willits Professor and Chief of the Division of Urology at Rutgers-New Jersey Medical School.
He is also the Program Director for the Urology Residency Program. Dr. Weiss specializes in urologic oncology surgery – treating
bladder cancer, renal cancer, prostate and testis cancer. He also treats patients with kidney stones and benign prostate disease.
He has particular expertise in laparoscopic and robotic surgery, as well as neobladder reconstruction and partial nephrectomy.
Dr. Weiss graduated magna cum laude from Brown University with a degree in chemistry and honors in biochemistry. He graduated from New York
University School of Medicine and completed his urology training at Mount Sinai School of Medicine in New York. He then completed a urologic oncology
fellowship at Memorial Sloan Kettering Cancer Center in New York, where he was named an American Cancer Society Fellow.
Dr. Weiss was a faculty member for several years at Rutgers- Robert Wood Johnson Medical School and the Cancer Institute of New Jersey and served as residency program director. He received several resident teaching awards during this time He has been listed many times in New York Magazine’s “Best Doctors”, New Jersey Magazine’s “Best Doctors”, Inside New Jersey’s “Top Doctors” and Castle and Connolly’s “America’s Top Doctors in Cancer”. Also, he received the National Medical Award in Urology from the Kidney and Urology Foundation of America. Currently, he has been selected to serve as President of the New York Section of the American Urological Association.
Dr. Weiss has presented his research nationally as well as internationally. He has received national research funding in the areas of prostate imaging and bladder cancer. He looks forward to bringing his clinical and academic leadership experience to Rutgers- New Jersey Medical School.
Dr. Alwaal is a board-certified and fellowship-trained reconstructive urologist and andrologist. He joined Rutgers New Jersey Medical School as an associate professor of urology. Dr. Alwaal earned his medical degree at King Abdulaziz University. He obtained a master's degree in surgical research from the University of British Columbia in Vancouver. He completed his residency in urology at McGill University in Montreal. He then continued his training and completed two fellowships' one in Urologic Reconstruction, Trauma, and the other in Andrology at the University of California, San Francisco (UCSF) with Drs. Benjamin Breyer and Tom Lue.
Dr. Alwaal is experienced in performing complex urethral and penile reconstruction for urethral stricture and cosmetic disfigurement, male incontinence, and surgical treatment for erectile dysfunction. He also specializes in andrology, which includes the treatment of male sexual dysfunction (penile prosthesis), male infertility, low testosterone, Peyronie's disease, and voiding dysfunction. He previously practiced in Saudi Arabia and at Marshall University in West Virginia where he was the director of men's health and reconstructive urology and the chief of urology at Cabell Huntington Hospital.
He has authored or co-authored more than 40 peer-reviewed publications, abstracts, and book chapters on urologic reconstruction, sexual dysfunction, trauma, and prosthetics. He is a research and awards committee member in the SMSNA.
Dr. Kovac joins Rutgers New Jersey Medical School as an Associate Professor of Urology and an Attending at University Hospital. He will also serve as the Associate Program Director of the Urology Residency Program.
Dr. Kovac is a board-certified and fellowship-trained urologic oncologist, specializing in the evaluation and treatment of cancers of the urinary tract, including prostate, kidney, bladder, testicular, adrenal and penile cancers. He earned his medical degree at McGill University in Montreal, Canada and also completed his residency in Urology at McGill. Evan then continued his training and completed a two-year fellowship in Urologic Oncology and Robotics at the renowned Cleveland Clinic in Cleveland, OH. Dr. Kovac is experienced in the latest diagnostic modalities and has specific expertise in ultrasound-MRI fusion biopsy for the diagnosis of prostate cancer. His surgical proficiency is broad and he is highly skilled in open, endoscopic and robotic techniques for the treatment of genitourinary cancers.
He has authored more than 30 peer-reviewed publications and book chapters on urologic oncology, has presented over 25 abstracts at national and international meetings, and is a leader in the optimization of prostate-specific antigen (PSA) screening for the early detection of prostate cancer. In addition, Dr. Kovac published an online training module for performing retroperitoneal lymph node dissection for the treatment of metastatic testicular cancer that is accessible to surgical trainees worldwide.
Prior to joining Rutgers, Evan practiced in New York at Montefiore Medical Center and was an Assistant Professor at the Albert Einstein College of Medicine. While at Montefiore, he led a collaboration with primary care physicians to create a novel prostate cancer screening decision aid designed specifically for multi-ethnic, underserved communities. He also led the establishment of a first-of-its-kind prostate cancer center in the Bronx.
Dr. Kovac's responsibilities will include expanding clinical and research programs at Rutgers, such as clinical trial development/participation and increasing prostate cancer and PSA screening awareness, especially among our high-risk, minority population.